RESEARCH TRIANGLE PARK, NORTH CAROLINA… Muses Labs, an Alzheimer’s disease digital health company, is supporting Buck Institute for Research on Aging in its next offering of the Memory Enhancement Immersion Program known as RE:Mind™. Attendees receive intensive education on the MEND™ Protocol over four days “off-site” in Sonoma, California, as well as getting their own personalized action plan generated by the systems at Muses Labs. Buck Institute initiated the RE:Mind program in August, the first time it pulled together a cooperative setting for the medical, behavioral, and systems teams. This is the third such setting for their collaboration.
Alzheimer’s disease is a chronic disease with multiple underlying medical causes. It is widely acknowledged that it will not be addressed by a single medication, but possibly by a broad-based personalized therapy. The latest research in epidemiology and lifestyle, in context with other conditions a person may have and medications they may be on, supports the observation that multiple interventions, custom-fitted to each person, can reduce and delay the onset of Alzheimer’s disease dramatically.
The MEND Protocol makes use of a person’s diagnostic status, genetic profile, blood chemistry, nutritional and metabolic tests, and family medical history to recommend a personalized combination of lifestyle, cognition interventions, pharmacological and non-pharmacological interventions. Due to the complexity of the protocol and quantity of data for each person, sophisticated technology developed by Muses Labs creates the unique plans for each attendee. They are coached to stay on track with their protocol and are retested every 90 days as the personalized protocol changes to match their progress.
Each RE:Mind attendee gets their MEND Protocol report as they meet in a one-on-one session with a physician knowledgeable in its intricacies. Other dedicated sessions include a registered dietitian and physical therapist from Sonoma Valley Hospital. General sessions introduce lifestyle changes related to diet, exercise, sleep, and stress. “Following through with the combination of interventions over time is the key to sustained improvement, and is a core message of RE:Mind,” says Denise M Kalos, VP Cognitive Wellbeing Programs at Buck Institute. “Also, early identification of risks and a focus on prevention is far better than waiting until any symptoms appear.”
“The Muses Labs team processed over 25 million pieces of data in its calculations for the previous RE:Mind events” noted Dr. John Q. Walker, CTO of Muses Labs. “My father worked on the Gemini and Apollo space missions in the late 60’s, and I can remember family dinner discussions on the importance of extremely low error rates. We’re achieving similar rates with the complex algorithms we’re now enhancing for MEND – all while meeting strong security and privacy requirements.”
Dave Coman, Muses Labs
Denise M Kalos, Buck Institute for Research on Aging